BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $66,000 | -2.9% | 826 | -10.9% | 0.00% | – |
| Q3 2019 | $68,000 | -34.6% | 927 | -15.5% | 0.00% | -100.0% |
| Q2 2019 | $104,000 | +92.6% | 1,097 | +62.8% | 0.00% | – |
| Q1 2019 | $54,000 | +800.0% | 674 | +518.3% | 0.00% | – |
| Q4 2018 | $6,000 | +20.0% | 109 | +62.7% | 0.00% | – |
| Q3 2018 | $5,000 | 0.0% | 67 | +34.0% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | -66.7% | 50 | -74.4% | 0.00% | – |
| Q4 2017 | $15,000 | +50.0% | 195 | +34.5% | 0.00% | – |
| Q3 2017 | $10,000 | – | 145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
| BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
| Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
| Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
| PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
| Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
| Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
| Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
| Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |